A delegation of around 40 doctors was welcomed at the headquarters of the company based in Bastia Umbra
FROM ALBANIA TO ITALY TO DISCOVER S&R FARMACEUTICI FROM UP CLOSE VISIT OF GYNAECOLOGISTS
NL|15 – 21 October 2016
Today REVIFAST®CARDIO was presented to all pharmaceutical representatives, the new product by S&R Farmaceutici is the brainchild of its Research and Development Division and will further enrich the Company’s extensive treatment offering.
The training of its own people is at the heart of S&R Farmaceutici values
The primary goal of S&R Farmaceutici is to provide continuous and constant updating for Medical Scientific Representatives…
NL|10 – 28 June 2016
MORE THAN JUST FEMALE INFERTILITY … We discover polycystic ovary syndrome
S&R Farmaceutici moves beyond national borders
It is with immense satisfaction that we announce the signing of the first foreign trade contract. During the meeting which recently took place at the S&R Farmaceutici headquarters in Bastia Umbra, the export manager and company management…
NL|08 – 13 May 2016
POLYCYSTIC OVARY SYNDROME is frequent in women with type 1 diabetes
6TH INTERACTIVE OBSTETRICS AND GYNAECOLOGY COURSE
S&R Farmaceutici will also be present at the 6th interactive Obstetrics and Gynaecology Course in Capri from May 12th to 14th; theme for this edition will be “Women’s health, between scientific evidence and new treatment opportunities”.
2nd CYCLE 2016
The second annual appointment of the 2nd 2016 cycle is being held, involving our entire sales network. An important event for gathering insights into new company strategies.
NL|07 – 22 April 2016
DIABETES: A GLOBAL EPIDEMIC that affects 422 million people…
FOR INTESTINAL REGULARITY, and more…